Published on 4 May 2024 on GuruFocus.com via Yahoo Finance
Insider Sale: CEO Stephen Davis Sells Shares of ACADIA Pharmaceuticals Inc (ACAD)
On May 2, 2024, Stephen Davis, the CEO of ACADIA Pharmaceuticals Inc (NASDAQ:ACAD), sold 11,427 shares of the company. The transaction was filed on the same day with the SEC.
Warning! GuruFocus has detected 4 Warning Signs with ACAD.
ACADIA Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of medicines to address unmet medical needs in central nervous system disorders.